Simon Levine-Gottreich

This inventor holds 1 USPTO granted patent. Top assignee: Absci LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon Levine-Gottreich. Retrieved from https://idiyas.com/inventor/simon-levine-gottreich-8v96500p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Levine-Gottreich: Innovator in Antibody Compositions

Introduction

Simon Levine-Gottreich is a notable inventor recognized for his contributions to the field of antibody compositions. He has made significant strides in the development of innovative solutions that have the potential to impact various medical applications.

Latest Patents

Simon holds a patent for "TL1A Associated Antibody Compositions and Methods of Use." This patent represents his commitment to advancing scientific knowledge and improving therapeutic options.

Career Highlights

Simon is currently employed at Absci LLC, a company dedicated to revolutionizing the biopharmaceutical industry through innovative technologies. His work at Absci LLC showcases his dedication to pushing the boundaries of what is possible in biotechnology.

Collaborations

Simon has collaborated with talented individuals such as Anand Sastry and Sharrol Bachas. These partnerships highlight the importance of teamwork in driving innovation and achieving groundbreaking results.

Conclusion

In summary, Simon Levine-Gottreich is a distinguished inventor whose work in antibody compositions exemplifies the spirit of innovation. His contributions continue to pave the way for advancements in the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…